Diltiazem
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Diltiazem and local guidelines before prescribing.
Mechanism
Non-dihydropyridine calcium channel blocker with negative chronotropic and inotropic effects.
Uses
Angina, hypertension, AF and SVT rate control.
Dosing
- Diltiazem (rate-limiting): standard-release 60 mg three times daily (60 mg twice daily in older people), max 360 mg/day. Modified-release preparations differ, so prescribe by brand.
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina - Diltiazem | 60 mg three times daily (twice daily in older people), max 360 mg/day. Prescribe MR by brand.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - Diltiazem AF rate control | Example: standard-release 60 mg orally three times daily, titrate by response/formulation. Avoid in HFrEF.
Cardiology: Cardiac Arrhythmias › 5.42 Two-Column Drug and Dose Table - Diltiazem | Selected HCM: immediate-release 60 mg three times daily initially; modified-release preparations are not interchangeable.
Cardiology: Cardiomyopathies › 3.54 Common Adult Drugs and Doses
4 more dose entries from the chapters
- Propranolol Thyrotoxic symptoms | 10–40 mg three to four times daily. Storm: e.g. 60–80 mg orally 4-hourly. Avoid in asthma (use a cardioselective beta blocker or diltiazem).
Endocrinology: Thyroid disease - Amlodipine, diltiazem, verapamil - maximum simvastatin dose 20 mg.
Endocrinology: Lipids and obesity - … times daily); diarrhoea is the dose-limiting effect; toxic in overdose; reduce dose in renal impairment; interactions — clarithromycin , ciclosporin, verapamil, diltiazem (CYP3A4 and P-glycoprotein) — myopathy and toxicity.
Rheumatology Anatomy Physiology Pharmacology - … effective as high dose with fewer side effects; diarrhoea is common; reduce or avoid in CKD; interactions - clarithromycin, erythromycin, ciclosporin, verapamil, diltiazem, some statins (toxicity, myopathy).
Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain
Side effects
Bradycardia, ankle oedema, headache, constipation, heart block.
Interactions
Beta-blockers risk bradycardia and block; raises levels of statins, ciclosporin, carbamazepine; avoid with ivabradine.
Contraindications and cautions
Heart block, severe bradycardia, left ventricular failure with pulmonary congestion
Monitoring
ECG, pulse, BP
Pregnancy and breastfeeding
Avoid unless essential
Renal and hepatic impairment
Reduce dose in renal and hepatic impairment
Overdose and reversal
Calcium, atropine, pacing
Special advice
Avoid in reduced EF heart failure and with beta-blockers if conduction disease.
More from the textbook: uses, cautions and other points
- Phase 0 - slower upstroke via L-type calcium channels (blocked by verapamil and diltiazem - slowing AV conduction).
Cardiology: Anatomy Physiology and Pharmacology - Interactions - CYP3A4 inhibitors ( clarithromycin , erythromycin, itraconazole, grapefruit juice with simvastatin), amiodarone and diltiazem (simvastatin dose limits), fibrates (gemfibrozil - avoid).
Cardiology: Anatomy Physiology and Pharmacology - Avoid — verapamil and diltiazem in HFrEF (negatively inotropic) unless a specialist advises; NSAIDs in heart failure; QT-prolonging combinations.
Cardiology: Presentations - Prescribing | Check renal function and K + ; no verapamil or diltiazem in HFrEF
Cardiology: Presentations - Drugs: Beta-blockers, rate-limiting calcium channel blockers (verapamil, diltiazem), digoxin, amiodarone, ivabradine.
Cardiology: Cardiology Emergencies - Beta-blocker (e.g. bisoprolol orally, or IV metoprolol in increments) or rate-limiting calcium channel blocker (diltiazem, verapamil) - avoid calcium channel blockers in heart failure with reduced EF.
Cardiology: Cardiology Emergencies
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (7 mentions)
- Cardiology: Presentations (2 mentions)
- Cardiology: Cardiology Emergencies (3 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (6 mentions)
- Cardiology: Heart Failure (2 mentions)
- Cardiology: Cardiac Arrhythmias (6 mentions)
- Cardiology: Cardiomyopathies (4 mentions)
- Endocrinology: Thyroid disease (1 mention)
- Endocrinology: Lipids and obesity (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Bowel Disorders (3 mentions)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Dialysis and Transplant (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: Connective tissue diseases (1 mention)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (1 mention)
- Surgery: Colorectal and anal surgery (3 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (3 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (3 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)